Indivior Pharmaceuticals Inc
(INDV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 299,000 | 284,000 | 293,000 | 271,000 | 276,000 |
| Cost of Goods | 79,000 | 38,000 | 39,000 | 46,000 | 50,000 |
| Gross Profit | 220,000 | 246,000 | 254,000 | 225,000 | 226,000 |
| Operating Expenses | 338,000 | 171,000 | 347,000 | 408,000 | 165,000 |
| Operating Income | -118,000 | 75,000 | -91,000 | -183,000 | 61,000 |
| Interest Expense | 9,000 | 9,000 | 5,000 | 10,000 | 10,000 |
| Other Income | 6,000 | 7,000 | 8,000 | 12,000 | 11,000 |
| Pre-tax Income | -121,000 | 73,000 | -88,000 | -181,000 | 62,000 |
| Income Tax | -23,000 | 11,000 | -11,000 | -46,000 | 23,000 |
| Net Income Continuous | -97,000 | 61,000 | -77,000 | -135,000 | 39,000 |
| Net Income | $-97,000 | $61,000 | $-77,000 | $-135,000 | $39,000 |
| EPS Basic Total Ops | -0.72 | 0.45 | -0.56 | -0.98 | 0.28 |
| EPS Basic Continuous Ops | -0.72 | 0.45 | -0.57 | -0.98 | 0.28 |
| EPS Diluted Total Ops | -0.72 | 0.45 | -0.54 | -0.98 | 0.27 |
| EPS Diluted Continuous Ops | -0.72 | 0.45 | -0.55 | -0.98 | 0.27 |
| EPS Diluted Before Non-Recurring Items | 0.44 | 0.37 | 0.43 | N/A | N/A |
| EBITDA(a) | $-112,000 | $80,000 | $-97,000 | $-176,000 | $67,000 |